Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Peer support boosts breastfeeding in preterm infants, study finds

NCT ID NCT03156946

Symptom relief Sponsor: Hospices Civils de Lyon Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether trained mothers who breastfed their own preterm babies could help other mothers of preterm infants breastfeed longer. Over 1,700 mother-infant pairs in European NICUs received either usual care or additional peer counseling during hospitalization and up to one month after discharge. The goal was to see if this support improved breastfeeding rates, infant health, and maternal well-being.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
breastfeeding mother-to-mother support
What this could lead to
If effective, this program could increase breastfeeding rates among preterm infants, leading to better health and development outcomes.
What could go wrong
The study is completed but results may not apply to all settings. Peer support effectiveness can vary, and the trial's stepped-wedge design has inherent limitations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,774 people

The number who actually took part.

Started

Nov 2018

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 35 weeks

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * any infant born \<35 weeks' gestation, * hospitalised in NICU before 24 hours old * and younger than 168 hours (7 days) old. Exclusion Criteria: * infant with foetal malformation that is life-threatening * infant with medical contraindication for breastfeeding * parent(s)' non-consent to be involved in the study * mother with prolonged medical contraindication for breastfeeding * mother with psychiatric disorders making breastfeeding support impossible * if no communication is possible with the mother * if the level of communication with the mother does not allow breastfeeding support, with or without a third party

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Infant, premature are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Breast Feeding Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Infant, premature

Contacts and locations

Locations

  • CH Lyon Sud

    Pierre-Bénite, France

  • CHC Clinique St-Vincent

    Rocourt, Belgium

  • CHU de Grenoble

    Grenoble, France

  • CHU site Félix Guyon

    Saint-Denis, Réunion, 97400, France

  • CHU vaudois

    Lausanne, Switzerland

  • Hôpital Femme Mère Enfant

    Bron, France

  • Hôpital Nord Ouest - Villefranche

    Gleizé, France

  • Hôpital des Enfants

    Toulouse, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.